Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. Feb 27, 2024; 16(2): 451-462
Published online Feb 27, 2024. doi: 10.4240/wjgs.v16.i2.451
Table 1 Comparison of general information between the patient groups

IAI group (%)
Non-IAI group (%)
t/χ2
P value
Sample size1565
Gender
    Male11 (73.3)35 (53.8)1.8940.169
    Female4 (26.7)30 (46.2)
Age65.63 ± 13.0357.75 ± 12.86-2.1190.046
BMI24.05 ± 3.4722.94 ± 2.99-1.2570.212
Smoking history
    Yes6 (40.0)20 (30.8)0.4730.491
    No9 (60.0)45 (69.2)
Hypertension
    Yes10 (66.7)33 (50.8)1.2390.266
    No5 (33.3)32 (49.2)
Diabetes
    Yes8 (53.3)38 (58.5)0.1310.717
    No7 (46.7)27 (41.5)
Preoperative anemia
    Yes12 (80.0)47 (72.3)0.3730.542
    No3 (20.0)18 (27.7)
Tumor site
    Left8 (53.3)37 (56.9)0.0640.801
    Right7 (46.7)28 (43.1)
Degree of differentiation
Medium and above9 (60.0)30 (46.2)0.9350.334
Low6 (40.0)35 (53.8)
Infiltration depth
    T3 + T48 (53.3)38 (58.5)0.1310.717
    T1 + T27 (46.7)27 (41.5)
Tumor diameter (cm)4.69 ± 1.154.79 ± 1.210.2930.770
Lymphatic metastasis
    Yes6 (40.0)23 (35.4)0.1120.737
    No9 (60.0)42 (64.6)
Gross classification of tumor
    Ulcerative4 (26.7)13 (20.0)0.5000.868
    Wettability7 (46.7)31 (47.7)
    Uplift type4 (26.7)21 (32.3)
Intraoperative bleeding388.58 ± 59.27402.23 ± 57.110.8100.428
Table 2 Comparison of laboratory indexes between the patient groups
Project
IAI group
Non-IAI group
t
P value
HGB (g/L)126.74 ± 19.58130.29 ± 21.130.5950.554
RBC (1012/L)4.09 ± 0.324.06 ± 0.28-0.2670.790
ALB (g/L)38.19 ± 2.1338.11 ± 2.31-0.1310.896
WBC (109/L)5.63 ± 1.035.46 ± 0.87-0.6570.513
PLT (109/L)359.33 ± 30.33291.41 ± 63.94-3.9970.000
NE (109/L)4.84 ± 0.703.44 ± 1.11-4.6840.000
LY (109/L)1.44 ± 0.181.73 ± 0.343.1740.002
CD45+ CD3-13.41 ± 0.8714.46 ± 1.552.5180.014
CD4/CD81.49 ± 0.0921.49 ± 0.110.1370.891
NLR3.43 ± 0.652.08 ± 0.84-5.7700.000
PLR253.87 ± 40.95177.65 ± 62.28-4.5080.000
SII1226.48 ± 245.55611.52 ± 285.96-7.6910.000
CEA (μg/L)4.32 ± 0.653.65 ± 0.84-2.9130.005
AFP (μg/L)3.63 ± 0.943.57 ± 0.91-0.2180.829
SCC (μg/L)1.40 ± 0.0861.40 ± 0.0970.0380.970
CA19-9 (Ku/L)18.78 ± 0.7518.84 ± 1.240.1690.866
CA-125 (Ku/L)10.64 ± 1.0411.13 ± 1.091.5760.119
CA15-3 (Ku/L)8.26 ± 1.067.87 ± 0.96-1.3780.172
Hsp90α (ng/mL)38.21 ± 2.8238.49 ± 2.690.3440.734
Table 3 Multivariate analysis of intra-abdominal infection in patients that underwent radical resection of colorectal cancer
Independent variable
B
S.E.
Wald
P value
OR
95%CI
Age0.0010.0550.0000.9901.0010.899-1.114
CD45+ CD3-0.3551.1850.0900.7651.4260.140-14.542
NLR-1.6150.6775.690.0171.1990.053-1.750
PLR-0.0220.0105.130.0241.9780.960-1.997
SII0.0100.0047.1940.0071.0101.003-1.018
CEA (μg/L)3.1311.4144.9030.02722.9051.433-366.157
Constant-20.78918.7671.2270.2680.000
Table 4 Diagnostic value of receiver operating characteristic curve evaluation index
Independent variable
Cutoff
AUC
Sensitivity
Specificity
Youden index
P value
95%CI
NLR2.670.8900.8670.8000.6670.0000.811-0.969
PLR213.180.8420.9330.7230.6560.0000.757-0.927
SII826.240.9370.2150.7850.7850.0000.886-0.989
CEA (μg/L)4.030.7280.6670.7080.3750.0060.595-0.861